Microsoft and Anthropic in Early Talks for Custom AI Chip Deal Following 5 Billion Investment
Canadian Biotech Sector Three Firms Draw Attention for 2026 Growth Potential
American Hospital Association Urges FTC and DOJ to Exempt Hospital Mergers from Premerger Notification Requirements
3M India Announces 506 Per Share Dividend Including Special Payout Reports 202 Profit Surge in Q4 FY26
JDcom Founder Pledges to Protect 900000 Workers from AI Displacement with Massive Retraining Initiative
Kevin Warsh Takes Helm at Federal Reserve Amid Trumps Push for Lower Rates Market Bets on Extended Hold
JOBY Q1 2026 Earnings EPS Beat Narrowing Losses as eVTOL Development Progresses
HGTY Q1 2026 Earnings NarrowerThanExpected Loss Drives Small Beat Shares Slip
Heritage Insurance Holdings Inc HRTG Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment
Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7
MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline
Commercecom Inc Series 1 CMRC Q1 2026 Earnings EPS Beat Drives Positive Market Reaction
VirTra Inc VTSI Edges Higher Consolidation Near Key Support
Intuitive Surgical ISRG Holds Steady Near 438 as Traders Weigh Support Levels
Silgan Holdings SLGN Holds Steady Near 38 as Shares Consolidate Between Key Support and Resistance
Blackbaud BLKB Rallies 12 as Software Stock Approaches Resistance at 3192
PodcastOne Inc PODC Surges 667 Key Levels and Market Dynamics
Retail Investors Boost Stakes in Vedanta MCX and 8 Other Stocks in Q4
Japanese Snack Maker Behind Shiruko Sand Eyes Singapore and Southeast Asia for Expansion
Oil Prices Advance as Markets Question Prospects for USIran Diplomatic Breakthrough
GLOBALFOUNDRIES Inc Announces Quantum Technology Solutions Initiative
ADP Private Payrolls Rising 109000 in April Surpass Expectations Signaling a Resilient Labor Market
AnheuserBusch InBev Shares Edge Lower as Revenue Misses Analyst Forecasts
Dillards Declares 030 Per Share Cash Dividend Continuing Shareholder Return Policy
Intrusion Inc INTZ Q1 2026 Earnings Earnings Miss Weighs Heavily as Revenue Data Remains Absent
Allogene Therapeutics ALLO Surges 755 as Biotech Momentum Builds